Home Based Tele-exercise for People With Chronic Neurological Impairments: COVID and Beyond

Brief Title

Home Based Tele-exercise for People With Chronic Neurological Impairments

Official Title

Home Based Tele-exercise for People With Chronic Neurological Impairments

Brief Summary

      To assess the impact of a 12-week virtual seated physical intervention on cardiovascular
      health and wellness in people with chronic neurological impairments (CNI).
    

Detailed Description

      This study aims to examine how effective seated Zoom exercise classes are for a person with
      CNI for addressing cardiovascular health, physical wellness and quality of life. If these
      classes prove to be effective, online platforms could be a viable avenue for those with CNI
      to exercise and increase/maintain wellness without having to leave their homes. The
      investigators are also attempting to determine if a class with a live instructor vs a
      pre-recorded class has an effect on motivation, compliance, exertion and
      modifications/safety.

      The entire process, including screening and consenting, will be done via Zoom and Redcap,
      potentially providing a blueprint for the future studies. This process can enable
      participants to participate in studies with minimal inconvenience, expense and effort of
      traveling for the consent process.
    

Study Phase

Phase 1/Phase 2

Study Type

Interventional


Primary Outcome

Change in heart rate


Condition

Neurologic Disorder

Intervention

Seated exercise

Study Arms / Comparison Groups

 Live zoom exercise classes
Description:  Participants will engage in a live zoom exercise session. Participants will undergo 45 minutes of aerobic exercise intervention, three times a week, for a period of 12 weeks. Exercise will include repetitive bouts of high intensity exercises with intermittent periods of rest or active recovery. circuit of moves like 'jabs', 'hooks' etc, and a strength and endurance class that promotes postural awareness.

Publications

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information


Recruitment Status

Behavioral

Estimated Enrollment

50

Start Date

January 22, 2021

Completion Date

December 31, 2023

Primary Completion Date

December 31, 2022

Eligibility Criteria

        Inclusion Criteria:

          1. Participants with chronic (>6 months) neurological impairments

          2. 18 to 75 years of age

          3. Participants who can provide a medical clearance to participate in the program

          4. Participants who can remain seated for at least one hour

          5. Heart rate/BP considerations, per each participant's MD

          6. Participants must be able to don/doff HR monitor without assistance, or have
             assistance if necessary

          7. Participants must maintain their current exercise/physical activity routine during the
             course of the study

          8. Clinically stable with no other neurological, medical or cognitive impairments

          9. Reliable Internet connection and ability to use Zoom platform

         10. Participants must speak and understand English

         11. No contraindication/limitations to exercise

         12. Currently exercising 2 days or less per week

        Exclusion Criteria:

          1. Participants with any cognitive impairment preventing safe and accurate participation
             in the program

          2. Medical issues preventing safe participation

          3. Other problems possibly contraindicating autonomous exercise at home if no supervision
             available.
      

Gender

All

Ages

18 Years - 75 Years

Accepts Healthy Volunteers

No

Contacts

Kathleen Friel, 6463519063, [email protected]

Location Countries

United States

Location Countries

United States

Administrative Informations


NCT ID

NCT04564495

Organization ID

Telex


Responsible Party

Sponsor

Study Sponsor

Burke Medical Research Institute


Study Sponsor

Kathleen Friel, Principal Investigator, Burke Medical Research Institute


Verification Date

April 2021